Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.285 USD | -2.65% | -12.28% | +28.54% |
May. 15 | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
Mar. 04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.54% | 81.33M | |
+9.87% | 115B | |
+11.71% | 106B | |
-2.59% | 21.96B | |
-13.61% | 21.87B | |
-5.29% | 19.21B | |
-3.09% | 18.08B | |
-38.57% | 17.71B | |
+6.27% | 14.32B | |
+33.86% | 12.42B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Wedbush Lowers Passage Bio's Price Target to $3 From $5, Maintains Outperform Rating